Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01951 JXR
RTNominal up2.430 +0.080 (+3.404%)
Others

30/07/2019 17:36

{I-bank focus}Morgan starts JXR (01951) at HK$11

[ET Net News Agency, 30 July 2019] Morgan Stanley initiated coverage on Jinxin
Fertility Group (01951) with an "overweight" rating and a target price of HK$11.
The research house views Jinxin as one of the best assisted reproductive services (ARS)
plays in China given its strong market leadership, good earnings visibility, and scarcity
value.
It owns two hospitals in Chengdu and Shenzhen and manages two facilities via service
agreements in China and the US. According to Frost & Sullivan (F&S), Jinxin's network
ranked No. 2 in China and the US by 2018 ARS revenue, with respective market shares of
3.9% and 2.5%. It recorded 2016-18 CAGRs of 63% and 64% for revenue and adjusted net
profit. Morgan projected 40%/56% 2018-21 CAGRs in revenue/adjusted net profit. (KL)

Remark: Real time quote last updated: 28/03/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.